Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Vaccines

  Free Subscription


Articles published in J Gen Virol

Retrieve available abstracts of 17 articles:
HTML format
Text format



Single Articles


    October 2018
  1. LI J, Hou G, Wang Y, Wang S, et al
    Protective efficacy of an inactivated chimeric H5 avian influenza vaccine against H5 highly pathogenic avian influenza virus clades 2.3.4.4 and 2.3.2.1.
    J Gen Virol. 2018 Oct 25. doi: 10.1099/jgv.0.001140.
    PubMed     Text format     Abstract available


  2. BICKERTON E, Dowgier G, Britton P
    Recombinant infectious bronchitis viruses expressing heterologous S1 subunits: potential for a new generation of vaccines that replicate in Vero cells.
    J Gen Virol. 2018 Oct 24. doi: 10.1099/jgv.0.001167.
    PubMed     Text format     Abstract available


    September 2018
  3. SCHRODER L, Klafack S, Bergmann SM, Fichtner D, et al
    Generation of a potential koi herpesvirus live vaccine by simultaneous deletion of the viral thymidine kinase and dUTPase genes.
    J Gen Virol. 2018 Sep 19. doi: 10.1099/jgv.0.001148.
    PubMed     Text format     Abstract available


    June 2018
  4. SLON CAMPOS JL, Poggianella M, Burrone OR
    Long-term stability of antibody responses elicited by Dengue virus envelope DIII-based DNA vaccines.
    J Gen Virol. 2018 Jun 20. doi: 10.1099/jgv.0.001094.
    PubMed     Text format     Abstract available


  5. NEROME K, Yamaguchi R, Fuke N, Izzati UZ, et al
    Development of a Japanese encephalitis virus genotype V virus-like particle vaccine in silkworms.
    J Gen Virol. 2018 Jun 7. doi: 10.1099/jgv.0.001081.
    PubMed     Text format     Abstract available


    April 2018
  6. LUTEIJN RD, Drexler I, Smith GL, Lebbink RJ, et al
    Mutagenic repair of double-stranded DNA breaks in vaccinia virus genomes requires cellular DNA ligase IV activity in the cytosol.
    J Gen Virol. 2018 Apr 20. doi: 10.1099/jgv.0.001034.
    PubMed     Text format     Abstract available


    February 2018
  7. BISWAS S, Smith GL, Roy EJ, Ward B, et al
    A comparison of the effect of molluscum contagiosum virus MC159 and MC160 proteins on vaccinia virus virulence in intranasal and intradermal infection routes.
    J Gen Virol. 2018;99:246-252.
    PubMed     Text format     Abstract available


    January 2018
  8. SUBRAMANIAM S, Yugo DM, Heffron CL, Rogers AJ, et al
    Vaccination of sows with a dendritic cell-targeted porcine epidemic diarrhea virus S1 protein-based candidate vaccine reduced viral shedding but exacerbated gross pathological lesions in suckling neonatal piglets.
    J Gen Virol. 2018 Jan 4. doi: 10.1099/jgv.0.001001.
    PubMed     Text format     Abstract available


  9. EVANS JS, Selden D, Wu G, Wright E, et al
    Antigenic site changes in the rabies virus glycoprotein dictates functionality and neutralizing capability against divergent lyssaviruses.
    J Gen Virol. 2018 Jan 4. doi: 10.1099/jgv.0.000998.
    PubMed     Text format     Abstract available


    November 2017
  10. YU Q, Liu Y, Du J, Liu Y, et al
    Porcine circovirus type 1 was undetected in vaccine but could be cultured in the cell substrate of Lanzhou lamb rotavirus vaccine.
    J Gen Virol. 2017 Nov 22. doi: 10.1099/jgv.0.000875.
    PubMed     Text format     Abstract available


  11. MOI ML, Ami Y, Muhammad Azami NA, Shirai K, et al
    Marmosets (Callithrix jacchus) as a non-human primate model for evaluation of candidate dengue vaccines: induction and maintenance of specific protective immunity against challenges with clinical isolates.
    J Gen Virol. 2017 Nov 21. doi: 10.1099/jgv.0.000913.
    PubMed     Text format     Abstract available


  12. DUFFY MR, Alonso-Padilla J, John L, Chandra N, et al
    Generation and characterization of a novel candidate gene therapy and vaccination vector based on human species D adenovirus type 56.
    J Gen Virol. 2017 Nov 20. doi: 10.1099/jgv.0.000978.
    PubMed     Text format     Abstract available


  13. TIAN D, Sooryanarain H, Matzinger SR, Gauger PC, et al
    Protective efficacy of a virus-vectored multi-component vaccine against porcine reproductive and respiratory syndrome virus, porcine circovirus type 2 and swine influenza virus.
    J Gen Virol. 2017 Nov 1. doi: 10.1099/jgv.0.000964.
    PubMed     Text format     Abstract available


    October 2017
  14. MALUQUER DE MOTES C, Smith GL
    Vaccinia virus protein A49 activates Wnt signalling by targetting the E3 ligase beta-TrCP.
    J Gen Virol. 2017 Oct 17. doi: 10.1099/jgv.0.000946.
    PubMed     Text format     Abstract available


  15. SEHATA G, Sato H, Yamanaka M, Takahashi T, et al
    Substitutions at residues 300 and 389 of the VP2 capsid protein serve as the minimal determinant of attenuation for canine parvovirus vaccine strain 9985-46.
    J Gen Virol. 2017 Oct 6. doi: 10.1099/jgv.0.000936.
    PubMed     Text format     Abstract available


    September 2017
  16. CARPENTIER DCJ, Hollinshead MS, Ewles HA, Lee SA, et al
    Tagging of the vaccinia virus protein F13 with mCherry causes aberrant virion morphogenesis.
    J Gen Virol. 2017 Sep 20. doi: 10.1099/jgv.0.000917.
    PubMed     Text format     Abstract available


    July 2017
  17. KANDEIL A, Kayed A, Moatasim Y, Webby RJ, et al
    Genetic characterization of highly pathogenic avian influenza A H5N8 viruses isolated from wild birds in Egypt.
    J Gen Virol. 2017 Jul 18. doi: 10.1099/jgv.0.000847.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Vaccines is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: